Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia

被引:10
作者
Chang, Christopher Y. [1 ]
Chabot, Peter [1 ]
Thomas, James P. [1 ]
机构
[1] PLC, Warrenton, VA 20186 USA
关键词
D O I
10.1016/j.otohns.2007.01.035
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: Objective evaluation of botulinum toxin A (BTX-A) dosing by determination of the statistical relationship between injection amount and duration of side effects and normal voice in adductor spasmodic dysphonia (SD) patients. From this information, to provide a rational guide to determine the initial and follow-up BTX-A amounts for injection. Study Design and Detting: Private laryngology clinic. Statistical analysis was performed on data obtained from 101 patients with SD. Results: Significant and predictable positive correlations were found between duration of side effects and duration of normal voice after BTX-A injection in patients with SD. Dose of BTX-A injected also appeared to have a significant positive correlation with duration of side effects, but a negative correlation with duration of normal voice. A trend toward more severe side effects was seen with larger doses of BTX-A injections. Conclusions and Significance: Increased understanding of the response of the human voice over time after BTX-A injection at various doses suggests new ideas to further increase clinical efficacy with the use of lower BTX-A doses. (C) 2007 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
引用
收藏
页码:894 / 899
页数:6
相关论文
共 19 条
  • [1] Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study
    Baker, R
    Jasinski, M
    Maciag-Tymecka, I
    Michalowska-Mrozek, J
    Bonikowski, M
    Carr, L
    MacLean, J
    Lin, JP
    Lynch, B
    Theologis, T
    Wendorff, J
    Eunson, P
    Cosgrove, A
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2002, 44 (10) : 666 - 675
  • [2] BASTIAN R, 2000, W SECTION TRIOLOGIC
  • [3] Botulinum toxin management of spasmodic dysphonia (Laryngeal dystonia): A 12-year experience in more than 900 patients
    Blitzer, A
    Brin, MF
    Stewart, CF
    [J]. LARYNGOSCOPE, 1998, 108 (10) : 1435 - 1441
  • [4] LARYNGEAL DYSTONIA - A SERIES WITH BOTULINUM TOXIN THERAPY
    BLITZER, A
    BRIN, MF
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1991, 100 (02) : 85 - 89
  • [5] Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia
    Chhetri, DK
    Mendelsohn, AH
    Blumin, JH
    Berke, GS
    [J]. LARYNGOSCOPE, 2006, 116 (04) : 635 - 642
  • [6] Botulinum neurotoxin in muscle overactivity
    Esquenazi, A
    [J]. JOURNAL OF HEAD TRAUMA REHABILITATION, 2005, 20 (06) : 563 - 567
  • [7] Botulinum A toxin (BOTOX) in the lower eyelid: Dose-finding study
    Flynn, TC
    Carruthers, JA
    Carruthers, JA
    Clark, RE
    [J]. DERMATOLOGIC SURGERY, 2003, 29 (09) : 943 - 951
  • [8] QUANTITATIVE MAPPING OF THE EFFECT OF BOTULINUM TOXIN INJECTIONS IN THE THYROARYTENOID MUSCLE
    GEORGE, EF
    ZIMBLER, M
    BILLER, HF
    WU, BL
    SANDERS, I
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1992, 101 (11) : 888 - 892
  • [9] Internalization and mechanism of action of clostridial toxins in neurons
    Grumelli, C
    Verderio, C
    Pozzi, D
    Rossetto, O
    Montecucco, C
    Matteoli, M
    [J]. NEUROTOXICOLOGY, 2005, 26 (05) : 761 - 767
  • [10] SERIAL NEUROPSYCHOLOGICAL STUDIES OF INTRAMUSCULAR BOTULINUM-A TOXIN IN HUMANS
    HAMJIAN, JA
    WALKER, FO
    [J]. MUSCLE & NERVE, 1994, 17 (12) : 1385 - 1392